Bank of America’s Blueprint Medicines BPMC Stock Holding History

Bank of America’s Portfolio BPMC Stock Details BPMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-79,200	Closed	-$8.54M	–	8173
2024 Q2	$8.54M	Hold	79,200	–	–	﹤0.01%	3098
2024 Q1	$7.51M	Hold	79,200	–	–	﹤0.01%	3254
2023 Q4	$7.31M	Buy	+79,200	New	+$5.13M	﹤0.01%	3217
2022 Q3	–	Sell	-25,000	Closed	-$1.26M	–	7842
2022 Q2	$1.26M	Buy	+25,000	New	+$1.46M	﹤0.01%	4696
2019 Q4	–	Sell	-84,600	Closed	-$6.22M	–	7089
2019 Q3	$6.22M	Buy	+84,600	New	+$7.31M	﹤0.01%	2987
2018 Q1	–	Sell	-29,200	Closed	-$2.2M	–	7110
2017 Q4	$2.2M	Buy	+29,200	New	+$2.05M	﹤0.01%	3863

Other funds holding BPMC

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bank of America's BPMC Position: Q3 2025 in Review

Bank of America sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 647,487 shares — an estimated $83M sold.

Bank of America first reported a position in BPMC in Q2 2015 and held it in 41 quarters. The position peaked at $83M in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

Bank of America reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
Bank of America sold 647,487 Blueprint Medicines shares in Q3 2025, an estimated $83M.
Bank of America first reported a position in Blueprint Medicines in Q2 2015 and held it in 41 quarters.
Bank of America's Blueprint Medicines position peaked at $83M in Q2 2025.
5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Bank of America's 13F filing for Q3 2025, filed 14 Nov 2025.